Inovio Pharmaceuticals Statistics

Total Valuation

LON:0A43 has a market cap or net worth of GBP 35.72 million. The enterprise value is -6.09 million.

Market Cap	35.72M
Enterprise Value	-6.09M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	50.96M
Shares Outstanding	n/a
Shares Change (YoY)	+37.06%
Shares Change (QoQ)	+28.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	47.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	163.01
PB Ratio	0.90
P/TBV Ratio	0.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.08
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.08

Financial Position

The company has a current ratio of 2.63, with a Debt / Equity ratio of 0.22.

Current Ratio	2.63
Quick Ratio	2.55
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-0.11
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -132.44% and return on invested capital (ROIC) is -77.74%.

Return on Equity (ROE)	-132.44%
Return on Assets (ROA)	-61.21%
Return on Invested Capital (ROIC)	-77.74%
Return on Capital Employed (ROCE)	-176.77%
Revenue Per Employee	1,635
Profits Per Employee	-557,267
Employee Count	134
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-73.50%
50-Day Moving Average	1.99
200-Day Moving Average	3.01
Relative Strength Index (RSI)	28.64
Average Volume (20 Days)	37,508

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.24

Income Statement

In the last 12 months, LON:0A43 had revenue of GBP 219,116 and -74.67 million in losses. Loss per share was -2.41.

Revenue	219,116
Gross Profit	-54.58M
Operating Income	-82.02M
Pretax Income	-74.67M
Net Income	-74.67M
EBITDA	-80.70M
EBIT	-82.02M
Loss Per Share	-2.41

Full Income Statement

Balance Sheet

The company has 52.91 million in cash and 8.72 million in debt, giving a net cash position of 44.19 million.

Cash & Cash Equivalents	52.91M
Total Debt	8.72M
Net Cash	44.19M
Net Cash Per Share	n/a
Equity (Book Value)	39.67M
Book Value Per Share	1.08
Working Capital	34.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -79.09 million and capital expenditures -395,994, giving a free cash flow of -79.49 million.

Operating Cash Flow	-79.09M
Capital Expenditures	-395,994
Free Cash Flow	-79.49M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-37,430.15%
Pretax Margin	-34,079.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0A43 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.06%
Shareholder Yield	n/a
Earnings Yield	-209.07%
FCF Yield	-222.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Jan 25, 2024
Split Type	Reverse
Split Ratio	0.0833333333

Scores

LON:0A43 has an Altman Z-Score of -28.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28.64
Piotroski F-Score	n/a